Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for HUYA Bioscience International

    Client Virtual Booth

    HUYA BIOSCIENCE INTERNATIONAL

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    HUYA Bioscience International
    China Flag
    Country
    Country
    China
    Address
    Address
    Shanghai Zhangjiang, Hi-Tech Park 780 Cailun Road, Suite 805, Pudong, Shanghai 201203
    Telephone
    Telephone
    +86 21 5132 3312
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://huyabio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/huyabio-international/
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    HUYABIO Files an NDA with the FDA for the Novel SHP2 Inhibitor HBI-2376
    HUYABIO Files an NDA with the FDA for the Novel SHP2 Inhibitor HBI-2376

    https://www.prnewswire.com/news-releases/huyabio-files-an-investigational-new-drug-application-with-the-fda-for-the-novel-shp2-inhibitor-hbi-2376-301365878.html

    PRNEWSWIRE
    31 Aug 2021
    Share Share
    HUYA Bioscience Presents Positive Data On HBI-8000 at Society for Immunotherapy
    HUYA Bioscience Presents Positive Data On HBI-8000 at Society for Immunotherapy

    https://www.prnewswire.com/news-releases/huya-bioscience-international-presents-positive-data-on-hbi-8000-at-society-for-immunotherapy-of-cancer-meeting-301168347.html

    PRNEWSWIRE
    09 Nov 2020
    Share Share
    HUYA Bioscience International Licenses the Novel SHP2 Inhibitor HBI-2376
    HUYA Bioscience International Licenses the Novel SHP2 Inhibitor HBI-2376

    https://www.huyabio.com/huya-bioscience-international-licenses-the-novel-shp2-inhibitor-hbi-2376-for-development-in-oncology/

    PRESS RELEASE
    05 Aug 2020
    Share Share
    HUYA International Licenses the Novel SHP2 Inhibitor HBI-2376
    HUYA International Licenses the Novel SHP2 Inhibitor HBI-2376

    https://www.prnewswire.com/news-releases/huya-bioscience-international-licenses-the-novel-shp2-inhibitor-hbi-2376-for-development-in-oncology-301105367.html

    PRNEWSWIRE
    04 Aug 2020
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search